Cargando…
Evidence-Based Medicine in Ophthalmic Journals During Covid-19 Pandemic
BACKGROUND: COVID-19 has erupted into our lives and forced rapid changes in all fields of medicine, causing a rush for publications that inevitably caused a shift away from the paradigm of evidence-based medicine (EBM). The objective of the present report is to assess and quantify this process. METH...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754265/ https://www.ncbi.nlm.nih.gov/pubmed/33363356 http://dx.doi.org/10.2147/OPTH.S279013 |
_version_ | 1783626155348197376 |
---|---|
author | Walter, Eyal Saban, Ori Jotkowitz, Alan Batash, Tomer Levy, Jaime |
author_facet | Walter, Eyal Saban, Ori Jotkowitz, Alan Batash, Tomer Levy, Jaime |
author_sort | Walter, Eyal |
collection | PubMed |
description | BACKGROUND: COVID-19 has erupted into our lives and forced rapid changes in all fields of medicine, causing a rush for publications that inevitably caused a shift away from the paradigm of evidence-based medicine (EBM). The objective of the present report is to assess and quantify this process. METHODS: We compared the levels of EBM of the publications in the ophthalmic literature on COVID-19 at the beginning of the pandemic and compared it to those of articles published the prior year during April 2019 for the three highest ranking journals in the field of comprehensive ophthalmology. RESULTS: COVID-19 publications ranked significantly lower (p<0.001). Time between submission and acceptance was significantly shorter for the COVID-19 publications (p<0.001), and significantly more publications were accepted without revisions (P<0.001). CONCLUSION: Though a shift away from EBM may be unavoidable in the early stages of a pandemic, we suggest that for the benefit of reliable information and informed decision-making, it is time to go back to EBM. |
format | Online Article Text |
id | pubmed-7754265 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-77542652020-12-23 Evidence-Based Medicine in Ophthalmic Journals During Covid-19 Pandemic Walter, Eyal Saban, Ori Jotkowitz, Alan Batash, Tomer Levy, Jaime Clin Ophthalmol Perspectives BACKGROUND: COVID-19 has erupted into our lives and forced rapid changes in all fields of medicine, causing a rush for publications that inevitably caused a shift away from the paradigm of evidence-based medicine (EBM). The objective of the present report is to assess and quantify this process. METHODS: We compared the levels of EBM of the publications in the ophthalmic literature on COVID-19 at the beginning of the pandemic and compared it to those of articles published the prior year during April 2019 for the three highest ranking journals in the field of comprehensive ophthalmology. RESULTS: COVID-19 publications ranked significantly lower (p<0.001). Time between submission and acceptance was significantly shorter for the COVID-19 publications (p<0.001), and significantly more publications were accepted without revisions (P<0.001). CONCLUSION: Though a shift away from EBM may be unavoidable in the early stages of a pandemic, we suggest that for the benefit of reliable information and informed decision-making, it is time to go back to EBM. Dove 2020-12-14 /pmc/articles/PMC7754265/ /pubmed/33363356 http://dx.doi.org/10.2147/OPTH.S279013 Text en © 2020 Walter et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Perspectives Walter, Eyal Saban, Ori Jotkowitz, Alan Batash, Tomer Levy, Jaime Evidence-Based Medicine in Ophthalmic Journals During Covid-19 Pandemic |
title | Evidence-Based Medicine in Ophthalmic Journals During Covid-19 Pandemic |
title_full | Evidence-Based Medicine in Ophthalmic Journals During Covid-19 Pandemic |
title_fullStr | Evidence-Based Medicine in Ophthalmic Journals During Covid-19 Pandemic |
title_full_unstemmed | Evidence-Based Medicine in Ophthalmic Journals During Covid-19 Pandemic |
title_short | Evidence-Based Medicine in Ophthalmic Journals During Covid-19 Pandemic |
title_sort | evidence-based medicine in ophthalmic journals during covid-19 pandemic |
topic | Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754265/ https://www.ncbi.nlm.nih.gov/pubmed/33363356 http://dx.doi.org/10.2147/OPTH.S279013 |
work_keys_str_mv | AT waltereyal evidencebasedmedicineinophthalmicjournalsduringcovid19pandemic AT sabanori evidencebasedmedicineinophthalmicjournalsduringcovid19pandemic AT jotkowitzalan evidencebasedmedicineinophthalmicjournalsduringcovid19pandemic AT batashtomer evidencebasedmedicineinophthalmicjournalsduringcovid19pandemic AT levyjaime evidencebasedmedicineinophthalmicjournalsduringcovid19pandemic |